The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy (Q34761180)

4 August 2017

1 reference

title

The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy (English)

1 reference

4 August 2017

A K Sjølie

1

1 reference

PubMed ID

12140727

4 August 2017

N Chaturvedi

series ordinal

2

1 reference

4 August 2017

1 August 2002

1 reference

Journal of Human Hypertension

4 August 2017

1 reference

4 August 2017

16 Suppl 3

1 reference

4 August 2017

S42-6

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001438

4 August 2017

0 references

cites work

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001438

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001438

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001438

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001438

Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001438

The angiotensin II receptor antagonist candesartan cilexetil (TCV-116) ameliorates retinal disorders in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001438

The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001438

7 January 2021

Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001438

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001438

7 January 2021

Is blood pressure a predictor of the incidence or progression of diabetic retinopathy?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001438

7 January 2021

Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001438

7 January 2021

Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001438

7 January 2021

Blood-retina barrier permeability in diabetes during acute ACE-inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001438

7 January 2021

Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001438

7 January 2021

Retinal neovascularization is prevented by blockade of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001438

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001438

1 reference

PubMed ID

12140727

Dimensions Publication ID

4 August 2017

0 references

1 reference

PubMed ID

12140727